Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Lung Cancer (Amsterdam, Netherlands)|August 3, 2015
Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controlsShu Xia, Chiang-Ching Huang, Min Le, et al.
International Journal of Biological Macromolecules|April 2, 2025
Mussel-inspired bifunctional chimeric peptides macromolecules functionalize 3D-printed porous scaffolds for enhanced antimicrobial and osseointegration properties in bone defect repairZiyang Bai, Yifan Zhao, Wenjun Zhang, et al.
Scientific Reports|March 17, 2016
Chromatin interactions and candidate genes at ten prostate cancer risk lociMeijun Du, Lori Tillmans, Jianzhong Gao, et al.
Materials Today. Bio|April 28, 2025
Dynamic multistage nanozyme hydrogel reprograms diabetic wound microenvironment: synergistic oxidative stress alleviation and mitochondrial restorationJingyu Yan, Yifan Zhao, Chenying Cui, et al.
BMC Genomics|May 14, 2013
Characterization of human plasma-derived exosomal RNAs by deep sequencingXiaoyi Huang, Tiezheng Yuan, Michael Tschannen, et al.
Regenerative Biomaterials|March 9, 2026
Cationic nanoparticles-enabled mouthwash combats precancerous oral mucosal inflammationMeijun Du, Kunyu Wang, Quanxin Ning, et al.
Prostate Cancer and Prostatic Diseases|June 3, 2018
Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patientsManish Kohli, Jian Li, Meijun Du, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 16, 2024
Nanomaterial-Mediated Reprogramming of Macrophages to Inhibit Refractory Muscle FibrosisXu Cheng, Hao Sui, Fangman Chen, et al.
Human Molecular Genetics|August 24, 2014
Prostate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genomeMeijun Du, Tiezheng Yuan, Kala F Schilter, et al.
Oncotarget|April 28, 2015
Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancerShu Xia, Manish Kohli, Meijun Du, et al.
Pageof 6